Xiaodan G. Kong

Dalian, CN 
Dalian, CN 

Overview

Xiaodan Kong practices practicing medicine in Dalian, China.

Their clinical expertise encompasses Sjogren Syndrome, Dry Mouth, Rheumatoid Arthritis (RA), and Arthritis.

They are actively involved in clinical research, co-authoring 27 peer reviewed articles and participating in 2 clinical trials.

Locations

Dalian, China
Other Locations
Dalian, China
Key Laboratory Of Biopesticide And Chemical Biology, Fuzhou, 350002, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Phase II, Multicenter Study to Evaluate the Preliminary Efficacy, Safety, and Pharmacokinetics of Subcutaneous JS005 in Chinese Adult Patients With Active Ankylosing Spondylitis
A Randomized, Double-blind, Placebo-controlled, Phase II, Multicenter Study to Evaluate the Preliminary Efficacy, Safety, and Pharmacokinetics of Subcutaneous JS005 in Chinese Adult Patients With Active Ankylosing Spondylitis
Enrollment Status: Completed
Publish Date: July 21, 2026
Intervention Type: Biological
Study Drug: JS005
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, Phase II, Multicenter Study to Evaluate the Preliminary Efficacy, Safety, and Pharmacokinetics of Subcutaneous JS005 in Chinese Adults With Active Non-radiographic Axial Spondyloarthritis
A Randomized, Double-blind, Placebo-controlled, Phase II, Multicenter Study to Evaluate the Preliminary Efficacy, Safety, and Pharmacokinetics of Subcutaneous JS005 in Chinese Adults With Active Non-radiographic Axial Spondyloarthritis
Enrollment Status: Terminated
Publish Date: July 21, 2026
Intervention Type: Biological
Study Drug: JS005
Study Phase: Phase 2
View 1 Less Clinical Trial

27 Total Publications

The associations between nailfold microvascular abnormalities and systemic inflammation or Th17/Treg dysregulation in rheumatoid arthritis.
The associations between nailfold microvascular abnormalities and systemic inflammation or Th17/Treg dysregulation in rheumatoid arthritis.
Journal: Frontiers in immunology
Published: April 06, 2026

Frequently Asked Questions about Xiaodan G. Kong

Is Xiaodan G. Kong a top-rated expert for Sjogren Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Xiaodan G. Kong is classified as an Experienced expert for Sjogren Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Xiaodan G. Kong participate in research or clinical trials?

Yes. Xiaodan G. Kong has published 27 articles and abstracts on conditions like Sjogren Syndrome. You can view a list of Xiaodan G. Kong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kong's expertise for a condition
ConditionClose
        View All 22 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile